1. Home
  2. BDRX vs HUGE Comparison

BDRX vs HUGE Comparison

Compare BDRX & HUGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDRX
  • HUGE
  • Stock Information
  • Founded
  • BDRX 2000
  • HUGE 1998
  • Country
  • BDRX United Kingdom
  • HUGE Canada
  • Employees
  • BDRX N/A
  • HUGE N/A
  • Industry
  • BDRX Biotechnology: Pharmaceutical Preparations
  • HUGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • BDRX Health Care
  • HUGE Health Care
  • Exchange
  • BDRX Nasdaq
  • HUGE Nasdaq
  • Market Cap
  • BDRX 9.6M
  • HUGE 7.8M
  • IPO Year
  • BDRX N/A
  • HUGE N/A
  • Fundamental
  • Price
  • BDRX $0.94
  • HUGE $0.14
  • Analyst Decision
  • BDRX Strong Buy
  • HUGE
  • Analyst Count
  • BDRX 1
  • HUGE 0
  • Target Price
  • BDRX $8.00
  • HUGE N/A
  • AVG Volume (30 Days)
  • BDRX 4.1M
  • HUGE 2.5M
  • Earning Date
  • BDRX 04-19-2024
  • HUGE 09-12-2024
  • Dividend Yield
  • BDRX N/A
  • HUGE N/A
  • EPS Growth
  • BDRX N/A
  • HUGE N/A
  • EPS
  • BDRX N/A
  • HUGE N/A
  • Revenue
  • BDRX $482,278.00
  • HUGE N/A
  • Revenue This Year
  • BDRX N/A
  • HUGE N/A
  • Revenue Next Year
  • BDRX N/A
  • HUGE N/A
  • P/E Ratio
  • BDRX N/A
  • HUGE N/A
  • Revenue Growth
  • BDRX N/A
  • HUGE N/A
  • 52 Week Low
  • BDRX $0.67
  • HUGE $0.13
  • 52 Week High
  • BDRX $9.64
  • HUGE $1.68
  • Technical
  • Relative Strength Index (RSI)
  • BDRX 49.28
  • HUGE 31.04
  • Support Level
  • BDRX $0.91
  • HUGE $0.14
  • Resistance Level
  • BDRX $1.20
  • HUGE $0.16
  • Average True Range (ATR)
  • BDRX 0.13
  • HUGE 0.02
  • MACD
  • BDRX 0.02
  • HUGE 0.01
  • Stochastic Oscillator
  • BDRX 24.26
  • HUGE 23.70

About BDRX Biodexa Pharmaceuticals plc American Depositary Shs

Biodexa Pharmaceuticals Plc is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

About HUGE FSD Pharma Inc. Class B Subordinate Voting Shares

FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

Share on Social Networks: